Nobilis Rismavac Suspensie en oplosmiddel voor suspensie voor injectie
Nobilis Rismavac Suspensie en oplosmiddel voor suspensie voor injectie
Authorised
- Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
Product identification
Medicine name:
Nobilis Rismavac Suspensie en oplosmiddel voor suspensie voor injectie
Nobilis Rismavac Suspension et solvant pour suspension injectable
Nobilis Rismavac Suspension und Lösungsmittel zur Herstellung einer Injektionssuspension
Active substance:
- Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
Target species:
-
Chicken (one day-old chick)
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live3.00/log10 50% cell culture infectious dose0.20millilitre(s)
Pharmaceutical form:
This information is not available for this product.
Withdrawal period by route of administration:
-
Intramuscular use
-
Chicken (one day-old chick)
-
Meat and offalno withdrawal period0 days
-
-
-
Subcutaneous use
-
Chicken (one day-old chick)
-
Meat and offalno withdrawal period0 days
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Available in:
-
Belgium
Package description:
- Nobilis Rismavac 1 MLP Bag with 600 ml of solvent for suspension for injection
- Nobilis Rismavac 1 MLP Bag with 500 ml of solvent for suspension for injection
- Nobilis Rismavac 1 Ampoule with 5000 doses of Suspension and 1 bag (MLP) with 1000 ml of solvent for suspension for injection
- Nobilis Rismavac 1 Ampoule with 4000 doses of Suspension and 1 bag (MLP) with 800 ml of solvent for suspension for injection
- Nobilis Rismavac 1 Ampoule with 2000 doses of Suspension and 1 bag (MLP) with 400 ml of solvent for suspension for injection
- Nobilis Rismavac 1 Ampoule with 1000 doses of Suspension and 1 bag (MLP) with 200 ml of solvent for suspension for injection
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet International B.V.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Labelling
This document does not exist in this language (English). You can find it
in another language below.
